What is Morgans saying about Cochlear and Northern Star shares?

Here's what the broker is saying about these big names following their updates.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A couple of very popular ASX 200 shares have released updates this week and the team at Morgans has been digging into them.

Does the broker rate them as buys this week? Let's see what it is saying after running the rule over their updates:

A man rests his chin in his hands, pondering what is the answer?

Image source: Getty Images

Cochlear Ltd (ASX: COH)

This hearing solutions company's shares came crashing down to earth on Wednesday after making a major downgrade to its FY 2026 guidance.

While some of this downgrade has been driven by geopolitical impacts, the main driver was a surprising decline in demand in developed markets.

Morgans notes that this demonstrates that cochlear implant (CI) demand is more cyclical and macro-sensitive than previously assumed. As a result, it has put a hold rating on its shares with a heavily reduced price target of $107.17 (from $214.93). This compares to its current share price of $92.88. It said:

COH has delivered a material downgrade to FY26 earnings, cutting guidance by c30% at the midpoint. While FX, geopolitics and cost actions contributed, the key takeaway is more fundamental, with CI demand, especially in developed markets, proving to be more cyclical and macro-sensitive than previously assumed.

This challenges the market's long-held view as a structural, volume-driven growth story largely insulated from economic cycles. While we view long-term fundamentals as intact, near-term earnings visibility has deteriorated materially, so we wait for demand stabilisation before re-engaging. We adjust our FY26-28 estimates and lower our target price to A$107.17 HOLD.

Northern Star Resources Ltd (ASX: NST)

Another ASX 200 share that Morgans has been looking at is gold miner Northern Star.

It was pleased with the company's performance, noting that gold sold came in above its revised expectations thanks to improvements following production issues.

In addition, it notes that a $500 million buy back has been announced, that is commencing today.

In response to the update, the broker has retained its buy rating and $30.00 price target on Northern Star's shares. This implies potential upside of 33% for investors. It said:

Gold sold of 381koz at AISC of A$2,709/oz beat our revised expectations, with sequential improvement across all three production centres following ongoing production issues. KCGM Mill Expansion on track for commissioning in early FY27; FY26 guidance has been provided and is above 1,500koz at AISC of A$2,600–2,800/oz. Net cash of A$320m; A$500m on-market buy-back announced, commencing ~23 April. We maintain our BUY rating, price target A$30.00ps (unchanged).

Motley Fool contributor James Mickleboro has positions in Cochlear. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Wooden blocks spelling rebound with coins on top.
Broker Notes

Can Life360 shares recover from the AI fuelled sell-off?

A leading expert looks into the AI-driven pressure hitting Life360 shares.

Read more »

An engineer takes a break on a staircase and looks out over a huge open pit coal mine as the sun rises in the background.
Broker Notes

Up 49% in a year, should you buy BHP shares for their 'stability and income'?

A leading expert delivers his forecast for BHP’s fast-rising shares.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Buy, hold, sell: Pro Medicus, Life360, A2 Milk shares

Expert analysts reveal their latest recommendations on 3 ASX 200 stocks.

Read more »

A woman sits in a cafe wearing a polka dotted shirt and holding a latte in one hand while reading something on a laptop that is sitting on the table in front of her
Broker Notes

Buy, hold, sell: Goodman Group, BHP, Westpac shares

ASX 200 shares are in the red for a fifth consecutive session amid stalled peace talks between the US and…

Read more »

Business man marking Sell on board and underlining it
Broker Notes

Experts name 3 ASX 200 shares to sell now

Let's see which shares are being tipped as sells this week.

Read more »

A man and a woman sit in front of a laptop looking fascinated and captivated.
Broker Notes

What is Morgans' updated view on Bank of Queensland and PLS shares?

These ASX 200 stocks are performing very differently this year.

Read more »

A construction worker sits pensively at his desk with his arm propping up his chin as he looks at his laptop computer.
Broker Notes

Are these ASX materials stocks a buy, hold or sell according to Morgans?

Morgans is optimistic on these shares.

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Analysts pick 3 ASX 200 stocks to buy

These stocks have been given buy ratings this week. Here's what you need to know about them.

Read more »